Comparison between Nivolumab and Regorafenib as Second-line Systemic Therapies after Sorafenib Failure in Patients with Hepatocellular Carcinoma
Article in Yonsei Medical Journal (January 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Article in Yonsei Medical Journal (January 2024)
Article in Analytical Chemistry (June 2023)
Article in European Journal of Internal Medicine (November 2022)